China Resources Pharmaceutical Group Limited (HKG:3320)

HKG:3320 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	31,790	35,810	32,229	39,705	22,303	25,004
Market Cap Growth	11.11%	11.11%	-18.83%	78.03%	-10.80%	-44.97%
Enterprise Value	140,786	134,493	125,637	127,867	104,251	93,118
Last Close Price	5.06	5.70	4.89	5.90	3.20	3.51
PE Ratio	8.97	10.10	7.59	10.03	4.82	6.39
Forward PE	7.50	7.10	6.11	8.75	5.81	6.69
PS Ratio	0.12	0.13	0.12	0.16	0.08	0.11
PB Ratio	0.62	0.34	0.32	0.44	0.19	0.26
P/TBV Ratio	1.94	1.94	1.63	2.09	0.98	1.07
P/FCF Ratio	-	2.25	4.11	1.74	3.22
P/OCF Ratio	-	1.88	3.25	1.42	2.57
PEG Ratio	0.75	-	-	-	-	0.62
EV/Sales Ratio	0.51	0.49	0.47	0.52	0.36	0.39
EV/EBITDA Ratio	8.88	8.70	8.40	9.68	7.11	7.08
EV/EBIT Ratio	10.71	10.55	10.33	11.61	8.63	8.40
EV/FCF Ratio	-	8.75	13.24	8.15	11.99
Debt / Equity Ratio	0.70	0.70	0.67	0.70	0.72	0.69
Debt / EBITDA Ratio	4.75	4.75	4.38	4.59	5.37	4.69
Debt / FCF Ratio	-	-	4.77	6.61	6.52	8.44
Asset Turnover	1.02	1.02	1.06	1.00	1.03	1.00
Inventory Turnover	6.30	6.30	7.07	6.99	7.42	7.17
Quick Ratio	0.82	0.82	1.00	0.94	0.95	0.92
Current Ratio	1.41	1.41	1.33	1.25	1.25	1.20
Return on Equity (ROE)	8.80%	8.80%	8.96%	8.09%	7.60%	7.12%
Return on Assets (ROA)	2.97%	2.97%	2.99%	2.80%	2.69%	2.92%
Return on Capital (ROIC)	4.65%	4.65%	4.72%	4.33%	4.13%	4.50%
Return on Capital Employed (ROCE)	9.50%	9.50%	9.80%	10.40%	9.20%	10.80%
Earnings Yield	11.15%	9.96%	13.18%	9.97%	20.74%	15.66%
FCF Yield	-	44.53%	24.32%	57.39%	31.05%
Dividend Yield	2.13%	2.52%	3.47%	2.71%	5.75%	4.06%
Payout Ratio	0.00%	-	22.83%	23.23%	20.00%	20.96%
Buyback Yield / Dilution	-	-	-	0.01%	0.02%
Total Shareholder Return	2.13%	2.52%	3.47%	2.71%	5.76%	4.08%

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.